Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Liver Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03741088
What this trial is testing

Study to Evaluate VORTX Rx (Theresa)

Who this might be right for
Carcinoma, HepatocellularLiver Metastases
HistoSonics, Inc. 8
Not applicableStudy completedNCT05475041
What this trial is testing

Perioperative Outcomes of Simultaneous Colorectal and Liver Resections

Who this might be right for
Colorectal Cancer MetastaticSurgical Procedure, Unspecified
Fondazione Poliambulanza Istituto Ospedaliero 766
Not applicableLooking for participantsNCT05068531
What this trial is testing

Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 100
Large-scale testing (Phase 3)Looking for participantsNCT05815082
What this trial is testing

CtDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal CancerLiver MetastasesCirculating Tumor Cell+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 490
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT02015169
What this trial is testing

Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis

Who this might be right for
HER2-positive Gastric Cancer Patients With Liver Metastasis
Samsung Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT03841305
What this trial is testing

Simultaneous Portal and Hepatic Vein Versus Portal Vein Embolizations for Hypertrophy of the Future Liver Remnant

Who this might be right for
Liver Metastasis Colon Cancer
University Hospital, Montpellier 64
Testing effectiveness (Phase 2)Study completedNCT00006010
What this trial is testing

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Alliance for Clinical Trials in Oncology 25
Testing effectiveness (Phase 2)UnknownNCT02184182
What this trial is testing

Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)

Who this might be right for
Liver Tumors
Azienda Ospedaliera di Padova 10
Not applicableWithdrawnNCT05240040
What this trial is testing

Treat Primary and Metastatic Liver Tumors

Who this might be right for
Intrahepatic CholangiocarcinomaLiver TumorMetastatic Cancer+1 more
Methodist Health System
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Not applicableLooking for participantsNCT07602504
What this trial is testing

China Metastatic Liver Cancer Clinical Registry Cohort Database

Who this might be right for
Liver MetastasesMetastases to LiverLiver Cancer+3 more
Anhui Provincial Hospital 2,000
Not applicableStudy completedNCT03176485
What this trial is testing

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Who this might be right for
Metastatic CancerMelanomaColon Cancer+6 more
University of Arizona 45
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune, Inc. 50
Not applicableActive Not RecruitingNCT02226276
What this trial is testing

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Bone MetastasesHER2-positive Breast CancerLiver Metastases+4 more
City of Hope Medical Center 10
Large-scale testing (Phase 3)Ended earlyNCT00023868
What this trial is testing

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Who this might be right for
Colorectal CancerMetastatic Cancer
American College of Radiology Imaging Network
Testing effectiveness (Phase 2)Study completedNCT03164655
What this trial is testing

Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network

Who this might be right for
Colorectal Cancer Metastatic
UNICANCER 20
Not applicableStudy completedNCT00728650
What this trial is testing

A Retrospective Review of Malignant Liver Tumors

Who this might be right for
Liver Cancer
University of Oklahoma 228
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Testing effectiveness (Phase 2)Study completedNCT00764595
What this trial is testing

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal TumorMetastatic Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 5
Next Page